On this page:
- Our Approach to Successfully Beating Cancer
- Clinical Trials
- Clinical Studies & New Medicines
- The Issels Treatment
- New Liquid Ionic Cesium Chloride
- Stem Cell Research
Our Approach to Successfully Beating Cancer
We get a lot of inquiries from people around the world so we decided to summarize the techniques we used to fight ATC cancer. We strongly believe that the methods that we used apply not only to successfully treating ATC cancer, but all forms of cancers. Read our approach to fight and beat the cancer.
This product was the #1 supplement on our list to successfully treat cancer and our doctors (who have never heard of this product) completely approved this product as a safe product that won’t interfere with any other treatments or therapies.
Poly-MVA was invented with the purpose of finding a non-toxic treatment for cancer. Many doctors recommend this nutritional supplement to their patients. Tests in animals and clinical experience in humans have shown that Poly-MVA has anti-cancer qualities. Poly-MVA is widely used in alternative cancer clinics in Mexico and other offshore locations. It has been widely used in the United States, usually under the guidance of a physician. While there have been no clinical trials up to now, there are sufficient reports of cures that trials are warranted. There are no known side affects of Poly-MVA. If you have any questions about the product, contact AMARC Enterprises at 1-866-POLY-MVA (866-765-9682).
According to the maker of Poly-MVA, it can provide the following benefits:
- Helps the body to produce energy
- Supports the liver in removing harmful substances from the body
- Assists in preventing cell damage
- Assists the body in removing heavy metals from the bloodstream
- Powerful antioxidant and detoxificant
- Prevents B-12 deficiency related mental disturbances in the elderly
- Supports nerve and neurotransmitter function
- Enhances white blood cell function
- Supports pH balance, helping to maintain oxygenation of cells and tissues
Poly-MVA was invented with the purpose of finding a non-toxic treatment for cancer. Many doctors recommend this nutritional supplement to their patients. Tests in animals and clinical experience in humans have shown that Poly-MVA has anti-cancer qualities. Poly-MVA is widely used in alternative cancer clinics in Mexico and other offshore locations. It has been widely used in the United States, usually under the guidance of a physician. While there have been no clinical trials up to now, there are sufficient reports of cures that trials are warranted. There are no known side affects of Poly-MVA.
Townsend Letter for Doctors and Patients
The Medical Journalist Report of Innovative Biologics: Cancer Remission Rates Increase from Use of the Safe and Effective Lipoic Acid Palladium Complex Poly-MVA
by Morton Walker, DPM
Poly-MVA: New hope for cancer patients
Wellness Directory of Minnesota
This new chemotherapy has shown promise in reversing all cancers, even multiple myeloma (bone cancer) and pancreatic cancer, however, for brain cancers, this is the first chemotherapy to break the blood brain barrier.
Frequently asked questions about Poly-MVA. You will find these FAQs really helpful. They not only answer questions about the product, usage, and safety, but also provide a directory of doctors in the USA who recommend and use Poly-MVA.
Poly-MVA Doctor Testimonials
Poly-MVA testimonials from doctors. Yes, these are doctors bragging about the wonderful things Poly-MVA has done for them and for their patients. Frankly we are not surprised that all these doctors across the USA are so excited about Poly-MVA because we have already experienced the wonders of this amazing product and are proud to share our story.
Ploy-MVA Customer Testimonials
Read these testimonials from patients to find out how Poly-MVA has made a difference in so many lives, especially cancer patients.
|Frankly, we are not surprised that all these doctors and patients across the USA are so excited about Poly-MVA because we have already experienced the wonders of this amazing product and are proud to share our story.|
Current active clinical trials for Anaplastic Thyroid Carcinoma Clinical trials sponsored by National Cancer Institute and other organizations that are currently in active phases.
Clinical trials are useful in preventing, diagnosing, and treating cancer. The Food and Drug Administration (FDA) often requires proof of effectiveness and safety of new anticancer drugs in a clinical trial before they give a nod to the public to sign up for these trials. Click on the image below to search for a clinical trial.
To find a clinical trial for Anaplastic Thyroid Carcinoma (ATC), in the Cancer Type/Keyword box, start typing “anaplastic thyroid” and you will see “Undifferentiated (Anaplastic) Thyroid Gland Cancer”, which is probably the closest thing you will find for ATC cancer. After entering your age and U.S. zip code, click Find Trials button. If there are no trials available, there is a phone number provided to call them.
Clinical Studies & New Medicines
Latest research and treatments for Anaplastic Thyroid Carcinoma (ATC). The following studies are published in The Journal of Clinical Endocrinology & Metabolism and were funded by American Cancer Society.
October 13, 2003
ONYX-015 virus kills Anaplastic Thyroid Carcinoma (ATC) cells
ONYX-015 virus kills anaplastic thyroid carcinoma (ATC) cells and enhances the antineoplastic effects of doxorubicin and paclitaxel. Our results suggest that the combination of ONYX-015 and radiotherapy should be considered for experimental trials in patients with anaplastic thyroid carcinoma.
April 1, 2001
Effect of Manumycin and Paclitaxel against Anaplastic Thyroid Carcinoma
We found that the combination of manumycin and paclitaxel enhanced the antitumor effects of both drugs against ATC. Our previous works have demonstrated that the combination of paclitaxel and manumycin improved their antineoplastic effect against ATC cells. In this paper we present data further showing that the combination of paclitaxel and manumycin provides improved antineoplastic activity in vivo without increased toxicity.
The Issels Treatment
An Integrative Approach to Cancer
Josef M. Issels, M.D., developed a Comprehensive Immunotherapy for cancer and achieved complete remission of “incurable cancers” without further recurrence for up to four decades. According to the FAQs on his site, “The Issels Immunotherapy Cancer Treatment is an Integrative non-toxic Immunotherapy that activates the patient’s own immune system to recognize and eliminate cancer cells.”
According to his website, his Immunotherapy is individualized, has no adverse side-effects, and is non-toxic. Dr; Issels started his hospital in Germany in 1951, when it was the first hospital of its kind offering Integrative Immunotherapy. Since the 1960s, the German equivalent of U.S. Medicare has covered the costs of Issels Immunotherapy. He moved his business to North America and now offers inpatient treatment in Mexico (since 1997) and outpatient treatment in Santa Barbara, CA (since 2004).
The Issels Immunotherapy for cancer has successfully treated stage 4 cancers and have documented proof of long-term remission. Dr. Issels passed away in 1998. His two sons now run the business. You may find The History of Issels Integrative Immuno-Oncology very interesting.
New Liquid Ionic Cesium Chloride
February 16, 2004
Cesium is one of the most alkaline elements. Dr. Otto Warburg won a Nobel prize for showing that cancer thrives in anaerobic (without oxygen), or acidic, conditions. Research by Keith Brewer, PhD and H.E. Satori has shown that raising the pH, or oxygen content, range of a cell to 8.0 creates a deadly environment for cancer. The pH scale ranges from 0 to 14, with numbers below 7 representing an acidic condition and above 7 representing an alkaline, or oxygenated, condition. When cesium is taken up by cancer cells, it raises the pH, or oxygen content, of the cell. The cells that die are absorbed and eliminated by the body.
Please also see Cell Power Drops.
Stem Cell Research
December 8, 2003
Novel gene therapy delivery uses stem cells that target, attack tumors
Genetically engineered stem cells can find tumors and then produce biological killing agents right at the cancer site. Researchers say that this might be the first gene therapy “delivery system” capable of homing in on and then attacking cancer that has metastasized — wherever it is in a patient’s body.
May 19, 2019
Research in Stem Cell Transplant
Canadian Cancer Society’s website explains how the latest research can benefit cancer, what are different types of transplants, and how the researchers are trying to make stem cell transplants not only safer, but also more effective.